Cannabis And Cannabinoid Research

84 researchers across 6 institutions

84 Researchers
6 Institutions
4 Grant PIs
14 High Impact

Research in cannabis and cannabinoids explores the complex interactions between cannabis compounds and biological systems. Investigations examine the pharmacological effects of cannabinoids, including their potential therapeutic applications and associated toxicological profiles. Studies employ diverse methodologies, from molecular and cellular assays to clinical trials and population health analyses, to understand mechanisms of action, identify optimal dosing, and assess safety. This field also investigates the behavioral and psychological impacts of cannabis use, contributing to substance abuse treatment strategies and mental health interventions.

This research holds particular relevance for Arkansas. The state's emerging regulated cannabis market creates opportunities for scientific inquiry into product efficacy, safety, and economic impact. Understanding the public health implications of cannabis use, including potential effects on mental health and substance abuse patterns within Arkansas communities, is a key focus. Furthermore, research into agricultural aspects of cannabis cultivation can inform best practices for Arkansas farmers and contribute to the state's agricultural economy.

This interdisciplinary area draws on expertise from pharmacology, toxicology, public health, neuroscience, behavioral science, and agricultural sciences. Engagement spans multiple Arkansas institutions, fostering collaborative approaches to address critical questions about cannabis and cannabinoids.

AI-generated overview
Filter by institution:
Filter by career stage:

Top Researchers

Name Institution h-index Citations Career Stage Badges
Lei Guo NCTR 52 18,086 High Impact
Matthew T. Feldner University of Arkansas 51 7,740 High Impact
Jerry W. King University of Arkansas 48 7,024
William E. Fantegrossi UAMS 41 5,170 Grant PI High Impact
Anna Radomińska‐Pandya UAMS 40 6,029 High Impact
Paul L. Prather UAMS 39 4,718 Grant PI
Ellen W. Leen‐Feldner University of Arkansas 36 3,531 High Impact
Jeffery H. Moran UAMS 29 3,769 High Impact
Erica L. Liebelt UAMS 28 2,302
Ali S. Taha UAMS 26 3,133 High Impact
Thaddeus Bartter UAMS 25 2,441 High Impact
Linda S. Von Tungeln NCTR 25 2,024 High Impact
Brett Adams UAMS 25 2,645 High Impact
Alicia M. Allen UAMS 24 1,895 High Impact
Michelle M. Vanlandingham NCTR 23 1,727 High Impact
Eric U. Yee UAMS 22 1,577 High Impact
Qiangen Wu NCTR 21 1,145 High Impact
Yuxi Li NCTR 19 1,322
Laura Ewing UAMS 17 1,023
Silvia Marino UAMS 17 743

Strategic Outlook

Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW

Global trajectory
5,038 works in 2026
-1.2% CAGR 2018–2026
Leadership concentration
5.1% held by global top 5 institutions
Fragmented HHI 21
Arkansas position
Arkansas not in global top 100
No AR institution among the top-100 contributors to this topic over the 2018–2026 window.

Top US institutions in this area

  1. 1 Johns Hopkins University 1,298
  2. 2 Harvard University 1,240
  3. 3 National Institutes of Health 1,061
  4. 4 Yale University 963
  5. 5 Columbia University 945

Cross-Institution Connections

Researchers at different institutions with overlapping expertise in Cannabis And Cannabinoid Research.

62%
Teah‐Marie Bynion University of Arkansas
60%
Morgan L. Ferretti University of Arkansas
57%
Daniella A. Fernandez University of Arkansas
Ellen W. Leen‐Feldner University of Arkansas
56%
54%
L. Riley Gournay University of Arkansas
51%
Yuxi Li NCTR
Hee-Seop Lee University of Arkansas
51%
Yuxi Li NCTR
49%
Ellen W. Leen-Feldner University of Arkansas

Researchers with Federal Grants

Browse All 84 Researchers in Directory